Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xcelerate
Mauldin, South Carolina, United Statesxcelerate.global ↗
- Ownership
- Private
- Employees
- ~12
- Development stage
- Other
01
Overview
Xcelerate is an active, publicly traded U.S. company (OTCMKTS:XCRT) focused on bridging engineering innovation with clinical care, specializing in consumer health and wellness products (not pure therapeutics), virtual healthcare technology platforms for global patient reach, and licensing/acquisition of medical device and skin care IP
- Therapeutic areas
- OtherDermatology
- Modalities
- DeviceVirtual health platformConsumer topical therapies
- Industry
- Consumable Medical Devices
02
Partnerships
HS Pharmaceuticals (licensed patent/IP portfolio) — manufacturing/marketing partners actively sought for OTC healthcare product development
Beyond the preview
Go deeper on Xcelerate.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xcelerate.